---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "CID-10 e CID-11 Rápidos"
developer_entity: "Daniel Correia"
bundle_id: "com.danproductions.medical.cid10"
app_store_id: "1525998679"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Free"
offline_capable: true
market_region: "US"
platforms: "iOS & Android"
app_last_updated: "2026-08-15"
report_date: "2026-08-24"
last_verified: "2026-08-24T00:00:00.000Z"
report_version: "2.0.6"
total_reviews: 4
overall_rating: 5
sentiment: "Frustrated"
sentiment_score: 25
confidence: "medium"
confidence_score: 0.45
top_complaint_theme: "Forced advertisements upon opening the app disrupt the intended use for quick information retrieval"
review_sample_size: 1
total_review_count: 1
analyzed_review_count: 1
data_age_days: 2
momentum_velocity: "maintenance"
intelligence_version: 3
tags: ["medical", "free", "frustrated sentiment", "mobile app", "app review", "app analysis", "healthcare", "professionals", "including"]
canonical_url: "https://marlvel.ai/apps/cid-10-e-cid-11-rapidos"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---

# CID-10 e CID-11 Rápidos Intelligence Report

## TL;DR {#tldr}

- **Category**: Medical · Free
- **Signal**: Rating 5 · Sentiment Frustrated
- **Recent focus**: Forced advertisements upon opening the app disrupt the intended use for quick information retrieval (top complaint)

> **TL;DR:** CID-10 e CID-11 Rápidos is a medical app by Daniel Correia, rated 5/5 by 4 users, with Frustrated user sentiment (25/100), available on iOS & Android.
>
> **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** CID-10 e CID-11 Rápidos faces Frustrated user sentiment (5/5 from 4 reviews), with users reporting forced advertisements upon opening the app disrupt the intended use for quick information retrieval as the primary concern.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 5/5 (4 reviews) |
| **User Mood** | Frustrated |
| **Category** | Medical |
| **Developer** | Daniel Correia |
| **Pricing** | Free |
| **Platforms** | iOS & Android |
| **Confidence** | Medium (0.45/1.0) |
| **Data Age** | 2d |

## Metadata & Market Performance
- **Publisher:** Daniel Correia
- **Category:** Medical
- **Target Audience:** Healthcare professionals including doctors, nurses, physiotherapists, and psychologists requiring rapid, offline access to medical classification codes.
- **Platforms:** iOS & Android
- **Version Reviewed:** 2.0.6
- **Report Date:** 2026-08-24
- **Signal Count:** 1 review analyzed
- **Confidence:** Medium (0.45/1.0)
- **App Store ID (iOS):** 1525998679
- **Bundle ID:** com.danproductions.medical.cid10
- **Google Play ID:** com.danproductions.medical.cid10
- **Performance Trend:** Stable
- **Data Window:** Analysis based on signals collected up to 2026-08-24

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** CID-10 e CID-11 Rápidos is a medical reference tool for healthcare professionals, providing offline access to ICD-10 and ICD-11 classification codes on iOS and Android.
**Why users hire it:** The app removes the connectivity dependency rivals require, allowing clinicians to access diagnostic codes in environments without reliable internet access.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] Simultaneous CID-10 and CID-11 Search:** Unified search engine queries both ICD-10 and ICD-11 databases concurrently via code, description, or clinical synonyms.
  * *User Intent:* Users want to quickly find relevant content or features.
- **[Differentiator] Offline Database:** Full ICD-10 and ICD-11 datasets stored locally on the device, requiring no internet connectivity.
  * *User Intent:* Users want uninterrupted access without internet dependency.
- **[Differentiator] PDF Export:** Generates professionally formatted PDF documents from selected codes for administrative workflows.
  * *User Intent:* Users seek enhanced value through premium features.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

CID-10 e CID-11 Rápidos occupies the niche of offline medical reference tools, maintaining a 5.0-star rating on iOS. The lack of Android ratings suggests the platform has yet to gain traction outside of the iOS user base.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Free
- **Tiers:** Free access to all features
- **Analysis:** The app is currently free and ad-supported, focusing on user acquisition within the medical reference market.

<!-- section:sentiment -->
## 🔴 User Sentiment (Medium Confidence: 1 of 1 review analyzed) {#user-sentiment}
- **Overall Rating:** 5/5
- **Platform Split:** iOS 5.0/5 (4 ratings)
- **Overall Sentiment:** Frustrated
- **Note:** The 5/5 store rating reflects cumulative history, while the Frustrated sentiment reflects recent user reviews analyzed by our AI pipeline.

### Top Complaints (Impact Areas)

- **Forced advertisements upon opening the app disrupt the intended use for quick information retrieval**

<!-- /section:sentiment -->
<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Offline database removes connectivity dependency
- Unified search queries ICD-10 and ICD-11 concurrently

**Growth Levers:**
- Implement premium ad-free tier for clinical users
- Refine search indexing to reduce manual navigation


<!-- /section:swot -->
## Recent Changes (v2 → v3) {#recent-changes}

The app's competitive positioning has shifted toward a more critical assessment of its ad-supported model, though the underlying product remains in a maintenance phase with no functional changes.

**Overall trend**: Stable
**Compared at**: 2026-08-24

### Medium-impact changes
- **[Added] Expanded Threat Assessment** (swot)
- **[Shifted] Refined Competitive Narrative** (positioning)

<!-- section:whats-new -->
## What's New

- **Latest (v2.0.6, 1 weeks ago):** General bug fixes and stability improvements.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Maintenance) {#momentum}

- Ships minor bug fixes regularly.
- Maintains maintenance-mode update cadence.

> **Cadence:** 1 total versions · 0 majors in last 6 months · 9 days since last update

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

CID-10 e CID-11 Rápidos is a medical app that is completely free.
It holds a 5/5 rating from 4 reviews.

<!-- speakable-start -->
> **Bottom Line:** Transitioning to a premium, ad-free model would resolve the primary friction point for clinical users, as the current ad-supported flow directly contradicts the app's core value of speed.
<!-- speakable-end -->

**Best for:** Healthcare professionals including doctors, nurses, physiotherapists, and psychologists requiring rapid, offline access to medical classification codes.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [PIVOT] Remove launch advertisements because they disrupt the primary clinical use case → increase retention
<!-- /section:pm-actions -->

<!-- section:outlook -->
### Outlook: Mixed

The medical reference market is shifting toward high-speed, frictionless interfaces that prioritize clinical efficiency. CID-10 e CID-11 Rápidos remains in a maintenance phase, and its current ad-supported model leaves it vulnerable to rivals that offer a cleaner, paid experience.

- 🔴 Forced launch advertisements disrupt the intended rapid-lookup workflow, which directly contradicts the app's offline-first value proposition.
- 🔴 Manual navigation requirements due to search limitations increase time-to-code, creating a high-friction experience for professional users.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 5/5 |
| Total Reviews | 4 |
| Sentiment | Frustrated (25/100) |
| Confidence | Medium |
| Pricing Model | Free |
| Platforms | iOS & Android |
| Key Features | 3 analyzed |
| Trend | Stable |
| Outlook | Mixed |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **CID-10 e CID-11 Rápidos** (this app) | 5/5 | Frustrated | Daniel Correia |
| [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo |
| [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. |
| [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase |
| [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System |
| [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor  Ltd. Şti. |

## Company Profile
- **Developer:** Daniel Correia
- **Website:** [https://alpenmob.com](https://alpenmob.com)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/cid-10-e-cid-11-r%C3%A1pidos/id1525998679?uo=4)
- **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.danproductions.medical.cid10&hl=en&gl=us)
- **Dev Site:** [Official Website](https://alpenmob.com)
- **Sources:** Developer website content, App store metadata, User reviews.

## Related Intel Reports
- [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating
- [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating
- [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating
- [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating
- [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor  Ltd. Şti.) · 4.8/5 Rating
- [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating
- [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating
- [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating
- [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating
- [*1O Patient Portal*](https://marlvel.ai/apps/1o-patient-portal) (1st Optimal, LLC) · N/A Rating

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes).
4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.45/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 1
- **Data Sources:** user reviews, developer website, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 2 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/cid-10-e-cid-11-rapidos)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.